molina healthcare inc. - MOH

MOH

Close Chg Chg %
286.26 -13.17 -4.60%

Pre-Market

273.09

-13.17 (4.60%)

Volume: 926.14K

Last Updated:

Feb 11, 2025, 3:59 PM EDT

Company Overview: molina healthcare inc. - MOH

MOH Key Data

Open

$286.00

Day Range

272.40 - 287.04

52 Week Range

272.40 - 423.92

Market Cap

$16.38B

Shares Outstanding

57.20M

Public Float

56.50M

Beta

0.54

Rev. Per Employee

N/A

P/E Ratio

13.90

EPS

$16.04

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

707.97K

 

MOH Performance

1 Week
 
-3.84%
 
1 Month
 
-4.55%
 
3 Months
 
-7.23%
 
1 Year
 
-32.03%
 
5 Years
 
88.33%
 

MOH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 341.643
Number of Ratings 18 Current Quarters Estimate 6.109
FY Report Date 03 / 2025 Current Year's Estimate 24.886
Last Quarter’s Earnings 5.05 Median PE on CY Estimate N/A
Year Ago Earnings 22.65 Next Fiscal Year Estimate 28.339
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 12 14 13
Mean Estimate 6.11 6.39 24.89 28.34
High Estimates 7.16 7.47 27.20 30.20
Low Estimate 4.82 6.07 21.90 27.09
Coefficient of Variance 8.62 6.13 5.23 3.32

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 6
OVERWEIGHT 2 2 2
HOLD 10 10 9
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Molina Healthcare Inc. - MOH

Date Name Shares Transaction Value
Jul 3, 2024 Daniel Cooperman Director 5,977 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 1,746,240.32
Jul 3, 2024 Jeff D. Barlow Chief Legal Officer 71,488 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $252.71 per share 18,065,732.48
Jul 3, 2024 Stephen H. Lockhart Director 2,442 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 713,454.72
Jul 3, 2024 Ronna E. Romney Director 17,133 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 5,005,577.28
Jul 3, 2024 Richard M. Schapiro Director 11,531 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 3,368,896.96
Jul 3, 2024 Debra Bacon EVP, Medicaid 6,689 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $252.71 per share 1,690,377.19
Jul 3, 2024 Debra Bacon EVP, Medicaid 6,505 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $292.16 per share 1,900,500.80
Jul 3, 2024 Steven J. Orlando Director 19,025 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 5,558,344.00
Jul 3, 2024 Dale B. Wolf Director 15,191 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 4,438,202.56
Jul 3, 2024 Richard C. Zoretic Director 6,647 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 1,941,987.52
Jul 3, 2024 James E. Woys Chief Operating Officer 53,682 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $252.71 per share 13,565,978.22
Jul 3, 2024 Barbara L. Brasier Director 3,876 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $292.16 per share 1,132,412.16
Mar 6, 2024 Joseph M. Zubretsky President & CEO; Director 333,217 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share 129,024,954.57
Mar 6, 2024 Joseph M. Zubretsky President & CEO; Director 349,952 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share 135,504,913.92
Mar 6, 2024 Joseph M. Zubretsky President & CEO; Director 360,591 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share 139,624,441.11
Mar 6, 2024 Joseph M. Zubretsky President & CEO; Director 392,660 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share 152,041,878.60
Mar 6, 2024 Maurice S. Hebert Chief Accounting Officer 10,058 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share 3,894,558.18
Mar 6, 2024 Maurice S. Hebert Chief Accounting Officer 9,608 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share 3,720,313.68
Mar 6, 2024 James E. Woys Chief Operating Officer 63,613 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $387.21 per share 24,631,589.73
Mar 6, 2024 James E. Woys Chief Operating Officer 58,964 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $387.21 per share 22,831,450.44

Molina Healthcare Inc. in the News